{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:02:28Z","timestamp":1761919348778},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.cancergencyto.2010.05.014","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T10:14:18Z","timestamp":1280830458000},"page":"81-87","source":"Crossref","is-referenced-by-count":8,"title":["Cytogenetic and molecular characterization of double inversion 3 associated with a cryptic BCR-ABL1 rearrangement and additional genetic changes"],"prefix":"10.1016","volume":"201","author":[{"given":"Reha","family":"Toydemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Hibbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashirekha","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.05.014_bib1","series-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib2","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood.V83.5.1348.bloodjournal8351348","article-title":"DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome","volume":"83","author":"Levy","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ajh.2830330310","article-title":"Apparent duplication of inv(3)(q21q26) in one of five cases with inv (3) in myelodysplastic syndromes and acute leukemia","volume":"33","author":"Walter","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib4","first-page":"99","article-title":"Double inversion (3)(q21q26) and monosomy 7 in a case of acute myeloid leukemia","volume":"111","author":"Lee","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2141.1995.tb05329.x","article-title":"Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study","volume":"91","author":"Secker-Walker","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/gcc.20033","article-title":"Molecular heterogeneity in AML\/MDS patients with 3q21q26 rearrangements","volume":"40","author":"Lahortiga","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib7","series-title":"ISCN: An International System for Human Cytogenetic Nomenclature","year":"2009"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib9","doi-asserted-by":"crossref","unstructured":"Gorre MEM M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876\u201380.","DOI":"10.1126\/science.1062538"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-8166-1-14","article-title":"FISH mapping of Philadelphia negative BCR\/ABL1 positive CML","volume":"18","author":"Virgili","year":"2008","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2008.12.013","article-title":"CAMELIA-Chronic Myeloid Leukaemia Project. Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results","volume":"191","author":"Holzerov\u00e1","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib12","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/blood.V97.11.3581","article-title":"Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis","volume":"97","author":"Kolomietz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood-2003-01-0123","article-title":"Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia","volume":"102","author":"Huntly","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/gcc.20487","article-title":"Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression","volume":"46","author":"Brazma","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib15","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib16","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood-2004-06-2208","article-title":"Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia","volume":"105","author":"Quintas-Cardama","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cancergencyto.2005.07.015","article-title":"The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction","volume":"165","author":"Han","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmed.2009.01.005","article-title":"Uniparental disomy in cancer","volume":"15","author":"Tuna","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib19","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1371\/journal.pgen.0010049","article-title":"Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes","volume":"1","author":"Lupski","year":"2005","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nature Med"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10428190009065838","article-title":"Consistent loss of heterozygosity at 14q32 in lymphoid blast crisis of chronic myeloid leukemia","volume":"39","author":"Sercan","year":"2000","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib22","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1371\/journal.pone.0001225","article-title":"SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS\/MPD-U and MPD","volume":"2","author":"Gondek","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmg.2005.01.002","article-title":"CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter)","volume":"48","author":"Schollen","year":"2005","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib24","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","article-title":"Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2007-11-123950","article-title":"Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy","volume":"112","author":"Jabbour","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.05.014_bib26","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2009-04-219410","article-title":"Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation","volume":"114","author":"Nicolini","year":"2009","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810002293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810002293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T22:49:25Z","timestamp":1591742965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810002293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0165460810002293"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.05.014","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}